Ameriprise’s Olema Pharmaceuticals OLMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5M | Buy |
1,172,863
+773,064
| +193% | +$3.29M | ﹤0.01% | 2355 |
|
|
2025
Q1 | $1.5M | Sell |
399,799
-49,899
| -11% | -$188K | ﹤0.01% | 3018 |
|
|
2024
Q4 | $2.62M | Sell |
449,698
-13,426
| -3% | -$78.3K | ﹤0.01% | 2760 |
|
|
2024
Q3 | $5.53M | Buy |
463,124
+22,058
| +5% | +$263K | ﹤0.01% | 2296 |
|
|
2024
Q2 | $4.77M | Buy |
441,066
+127,820
| +41% | +$1.38M | ﹤0.01% | 2350 |
|
|
2024
Q1 | $3.55M | Buy |
313,246
+52,889
| +20% | +$599K | ﹤0.01% | 2574 |
|
|
2023
Q4 | $3.65M | Sell |
260,357
-88,918
| -25% | -$1.25M | ﹤0.01% | 2558 |
|
|
2023
Q3 | $4.31M | Buy |
349,275
+119,910
| +52% | +$1.48M | ﹤0.01% | 2395 |
|
|
2023
Q2 | $2.07M | Buy |
+229,365
| New | +$2.07M | ﹤0.01% | 2850 |
|
|
2021
Q4 | – | Sell |
-210,926
| Closed | -$5.82M | – | 4021 |
|
|
2021
Q3 | $5.82M | Sell |
210,926
-311,148
| -60% | -$8.59M | ﹤0.01% | 2280 |
|
|
2021
Q2 | $14.6M | Buy |
522,074
+57,060
| +12% | +$1.6M | ﹤0.01% | 1601 |
|
|
2021
Q1 | $15.4M | Buy |
465,014
+98,412
| +27% | +$3.27M | 0.01% | 1533 |
|
|
2020
Q4 | $17.6M | Buy |
+366,602
| New | +$17.6M | 0.01% | 1315 |
|